Journal article
Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies
Annals of hematology, Vol.95(4), pp.575-580
03/2016
DOI: 10.1007/s00277-016-2588-z
PMCID: PMC4944817
PMID: 26747296
Abstract
The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting. We identified 10,293 HIV+ patients who were followed for a median duration of 53 months. Of the 10,293 patients with HIV, 229 (2.2 %) were diagnosed with a HM. Over 85 % of patients in both groups were tested; no significant difference in the prevalence of chronic HBV or HCV was noted between the HM positive (n = 229) and HM negative (n = 9992) patients. The serum protein electrophoresis test was performed for 1371 of the 10,221 patients. HM positive patients, compared to HM negative, were more likely to be tested for paraproteins (OR 3.3, 95 % CI 2.5-4.4) and more likely to have a discrete paraprotein band (OR 3.3, 95 % CI 1.2-8.9). Discrete paraproteins exclusively correlated with the development of plasma cell malignancies. Faint or oligoclonal protein bands were seen in high grade B cell lymphomas but did not show a significant correlation with HM development. Chronic hepatitis B or C infections did not correlate with the development of HM in HIV; however, viral influence on host gene transformation may have been impacted by anti-viral therapy limiting the duration of high viremic states.
Details
- Title: Subtitle
- Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies
- Creators
- Erin Jou - Albert Einstein College of MedicineOleg Gligich - Albert Einstein College of MedicineAlvita C Y Chan - Chinese University of Hong KongDiwakar Mohan - Johns Hopkins UniversityUriel R Felsen - Albert Einstein College of MedicineSabarish Ayyappan - University Hospitals Cleveland Medical CenterHenny H Billett - Albert Einstein College of MedicineEdwin P Hui - Chinese University of Hong KongAnthony T C Chan - Partner State Key Laboratory of Oncology in South China, Sir Y K Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong KongRadha Raghupathy - Chinese University of Hong Kong
- Resource Type
- Journal article
- Publication Details
- Annals of hematology, Vol.95(4), pp.575-580
- DOI
- 10.1007/s00277-016-2588-z
- PMID
- 26747296
- PMCID
- PMC4944817
- NLM abbreviation
- Ann Hematol
- ISSN
- 0939-5555
- eISSN
- 1432-0584
- Grant note
- AI-051519 / NIAID NIH HHS K23 MH106386 / NIMH NIH HHS P30 AI051519 / NIAID NIH HHS UL1 TR001073 / NCATS NIH HHS
- Language
- English
- Date published
- 03/2016
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984360037402771
Metrics
25 Record Views